| 130.31 Delayed Data As of Jul 19 |  -1.76 / -1.33%Today’s Change | 121.00 Today|||52-Week Range 148.99 | +0.98% Year-to-Date |
| Previous close | 132.07 |
| Today’s open | 132.25 |
| Day’s range | 130.19 - 132.39 |
| Volume | 8,340,239 |
| Average volume (3 months) | 6,853,536 |
| Market cap | $346.0B |
| Earnings growth (last year) | +1,087.50% |
| Earnings growth (this year) | +5.35% |
| Earnings growth (next 5 years) | +6.23% |
| Revenue growth (last year) | +6.61% |
| P/E ratio | 24.1 |
| Price/Sales | 4.26 |
| Price/Book | 5.81 |
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | -0.29 | -0.67% |
| NVSNovartis | -0.70 | -0.74% |
| MRKMerck | -1.30 | -1.57% |
| AZNAstraZeneca | -0.61 | -1.50% |
| Next reporting date | October 15, 2019 |
| EPS forecast (this quarter) | $2.08 |
| Annual revenue (last year) | $81.5B |
| Annual profit (last year) | $15.3B |
| Net profit margin | 18.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Alex Gorsky |
Chief Financial Officer & Executive Vice President Joseph J. Wolk |
Corporate headquarters New Brunswick, New Jersey |
